Word

L

Status

Dead

Status Code

604

Status Date

Saturday, January 27, 2018

Serial Number

87425805

Mark Type

3000

Filing Date

Wednesday, April 26, 2017

Published for Opposition

Tuesday, September 19, 2017

Abandoned Date

Saturday, January 27, 2018

Trademark Owner History

SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. - Owner At Publication

Classifications

5 Pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicines for human purpose, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biological preparations for medical purposes, namely, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biochemical medicines, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Drugs for medical purposes in the nature of medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Injections, namely, vaccines and injectable medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Active pharmaceutical ingredients in the nature of components of finished pharmaceutical preparations, which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Dietetic substances adapted for medical use, namely, dietetic beverages and food for medical purposes, the foregoing dietetic food and beverages containing vitamin, protein, minerals, lecithin, glucose, amino acid, folic acid, fruit juice, fruit oil, honey, seaweed glue, fish oil, cod-liver oil, cubilose, restoratives, plant fibre, nutrition powder, nutrient capsule, nutrient tablets, and containing mineral food-supplements, the foregoing dietetic foods and beverages are used for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases

Color is not claimed as a feature of the mark.
The mark consists of a hexagon or cube shape formed by three L shapes of equal size. The top and bottom-right L shapes form an outward point, with the bottom-left L shape flipped, with the point going inward.
LLL
L L L

Trademark Events

Jan 29, 2018

Abandonment Notice Mailed - Inter Partes Decision

Jan 27, 2018

Abandonment - After Inter Partes Decision

Jan 27, 2018

Opposition Terminated No. 999999

Jan 27, 2018

Opposition Sustained No. 999999

Oct 19, 2017

Opposition Instituted No. 999999

Oct 19, 2017

Opposition Papers Received At Ttab

Sep 19, 2017

Official Gazette Publication Confirmation E-Mailed

Sep 19, 2017

Published For Opposition

Aug 30, 2017

Notification Of Notice Of Publication E-Mailed

Jul 27, 2017

Approved For Pub - Principal Register

Jul 27, 2017

Examiner's Amendment Entered

Jul 27, 2017

Notification Of Examiners Amendment E-Mailed

Jul 27, 2017

Examiners Amendment E-Mailed

Jul 27, 2017

Examiners Amendment -Written

Jul 24, 2017

Assigned To Examiner

May 4, 2017

Notice Of Design Search Code E-Mailed

May 3, 2017

New Application Office Supplied Data Entered In Tram

Apr 29, 2017

New Application Entered In Tram